NIH/NIDDK DRC
Diabetes Research Center
Featured News & Media
The National Institute of Health National Institute of Diabetes and Digestive and Kidney Diseases (NIH NIDDK) has renewed their commitment...
The U.S. Food and Drug Administration has approved Tzield (teplizumab) injection to delay the loss of the body’s own insulin production for pediatric patients aged 8 to 17 years recently diagnosed...
In recognition of her extraordinary scientific career and transformative contributions to immunology, Professor at Diabetes Center, Department of Surgery, Gladstone-UCSF Institute of Genomic...
UCSF Diabetes Center director Mark Anderson, MD, PhD, a pioneer in diabetes research and professor of Medicine at UC San Francisco, has been elected to the National Academy of Sciences — one of the...